Melan-A Recombinant Rabbit Monoclonal Antibody (SC56-02), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA532217-Each-of-1 | In Stock | ₹ 47,481.50 |
PIMA532217 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 47,481.50
GST (18%): ₹ 8,546.67
Total Price: ₹ 56,028.17
Antigen
Melan-A
Classification
Monoclonal
Concentration
1 mg/mL
Formulation
TBS with 0.05% BSA, 40% Glycerol and 0.05% sodium azide, pH 7.4
Gene Accession No.
Q16655
Gene Symbols
MLANA
Immunogen
Synthetic peptide within Human MelanA aa 2-43
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Applications
Flow Cytometry, Immunohistochemistry, Immunohistochemistry (Paraffin), Western Blot
Clone
SC56-02
Conjugate
Unconjugated
Gene
MLANA
Gene Alias
A930034P04Rik, Antigen LB39-AA, antigen SK29-AA, MART1, MART-1, melan-A, melanoma antigen recognized by T-cells 1, melanoma associated antigen recognized by T-cells 1, MLANA, Protein Melan-A
Host Species
Rabbit
Purification Method
Protein A
Regulatory Status
RUO
Gene ID (Entrez)
2315
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Related Products
Description
- Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems
- The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits
- Then, individual clones are screened to select the best candidates for production
- The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire
- MART1 is involved in melanosome biogenesis by ensuring the stability of GPR143
- Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes.